BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy.
作者信息
Cario Gunnar, Leoni Veronica, Conter Valentino, Baruchel André, Schrappe Martin, Biondi Andrea
机构信息
University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
Dept. of Pediatrics, University of Milano-Bicocca, FondazioneMBBM/Ospedale San Gerardo, Monza, Italy.
出版信息
Haematologica. 2020 Sep 1;105(9):2200-2204. doi: 10.3324/haematol.2018.207019.
Abstract
摘要
相似文献
1
BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy.儿童BCR-ABL1样急性淋巴细胞白血病与靶向治疗
Haematologica. 2020 Sep 1;105(9):2200-2204. doi: 10.3324/haematol.2018.207019.
2
BCR-ABL1 positive lymphoblastic lymphoma - should it be treated like a B-lymphoblastic leukemia with (9;22);BCR-ABL1?
Leuk Lymphoma. 2020 May;61(5):1265-1267. doi: 10.1080/10428194.2019.1706736. Epub 2019 Dec 26.
3
BCR/ABL1-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy.BCR/ABL1 样急性淋巴细胞白血病：从诊断方法到分子靶向治疗。
Acta Haematol. 2022;145(2):122-131. doi: 10.1159/000519782. Epub 2021 Nov 24.
4
MicroRNA signature in BCR-ABL1-like and BCR-ABL1-positive childhood acute lymphoblastic leukemia: similarities and dissimilarities.BCR-ABL1样和BCR-ABL1阳性儿童急性淋巴细胞白血病中的微小RNA特征：异同点
Leuk Lymphoma. 2014 Aug;55(8):1942-5. doi: 10.3109/10428194.2013.858813. Epub 2014 Feb 14.
5
Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.根据微小残留病水平采用风险导向疗法治疗的BCR-ABL1样急性淋巴细胞白血病患儿的预后
J Clin Oncol. 2014 Sep 20;32(27):3012-20. doi: 10.1200/JCO.2014.55.4105.
6
Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.伴有 CCDC88C-PDGFRB 融合的复发 BCR-ABL1 样急性淋巴细胞白血病患者中酪氨酸激酶抑制剂治疗的获益。
Int J Hematol. 2021 Feb;113(2):285-289. doi: 10.1007/s12185-020-03006-5. Epub 2020 Sep 19.
7
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia.BCR/ABL1阳性急性淋巴细胞白血病复发为BCR/ABL1阴性急性淋巴细胞白血病。
Leuk Lymphoma. 2013 Sep;54(9):2065-7. doi: 10.3109/10428194.2012.762513. Epub 2013 Feb 5.
8
BCR/ABL1-like acute lymphoblastic leukemia: How to diagnose and treat?BCR/ABL1 样急性淋巴细胞白血病：如何诊断和治疗？
Cancer. 2019 Jan 15;125(2):194-204. doi: 10.1002/cncr.31848. Epub 2018 Dec 18.
9
A novel e8a2 BCR-ABL1 fusion with insertion of RALGPS1 exon 8 in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.一名复发的费城染色体阳性急性淋巴细胞白血病患者中一种新型的e8a2 BCR-ABL1融合基因，伴有RALGPS1外显子8插入。
Leuk Lymphoma. 2011 May;52(5):919-21. doi: 10.3109/10428194.2011.555025. Epub 2011 Feb 21.
10
Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?急性淋巴细胞白血病中 BCR::ABL1 治疗后阳性：我们应该追踪吗？
Am J Hematol. 2023 Oct;98(10):E269-E271. doi: 10.1002/ajh.27022. Epub 2023 Jul 14.
引用本文的文献
1
The role of IKZF1 rs4132601 and Δ4-7 somatic deletion in acute lymphoblastic leukemia: a bioinformatics and case-control study.IKZF1 rs4132601和Δ4-7体细胞缺失在急性淋巴细胞白血病中的作用：一项生物信息学及病例对照研究
Mol Biol Rep. 2025 May 22;52(1):487. doi: 10.1007/s11033-025-10608-x.
2
RNA-sequencing: A reliable tool to unveil transcriptional landscape of paediatric B-other acute lymphoblastic leukaemia.RNA测序：揭示儿童B-其他急性淋巴细胞白血病转录图谱的可靠工具。
Br J Haematol. 2025 May;206(5):1355-1365. doi: 10.1111/bjh.20056. Epub 2025 Mar 30.
3
Unraveling the Genetic Heterogeneity of Acute Lymphoblastic Leukemia Based on NGS Applications.基于二代测序技术应用解析急性淋巴细胞白血病的遗传异质性
Cancers (Basel). 2024 Nov 26;16(23):3965. doi: 10.3390/cancers16233965.
4
Philadelphia chromosome-like acute lymphoblastic leukemia with concomitant rearrangements of CRLF2 and ABL1: a pediatric case report.伴有 CRLF2 和 ABL1 重排的费城染色体样急性淋巴细胞白血病：一例儿科病例报告。
BMC Pediatr. 2024 Aug 10;24(1):517. doi: 10.1186/s12887-024-04991-w.
5
Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia.高危儿童急性淋巴细胞白血病的生物标志物
Cancers (Basel). 2024 Feb 21;16(5):858. doi: 10.3390/cancers16050858.
6
Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia.儿童急性淋巴细胞白血病分子亚型的多模态分类
NPJ Precis Oncol. 2023 Dec 8;7(1):131. doi: 10.1038/s41698-023-00479-5.
7
Clinical features and outcomes of fusion gene defined adult Ph-negative B-cell precursor acute lymphoblastic leukemia patients: A single institutional report.融合基因定义的成人 Ph 阴性 B 细胞前体急性淋巴细胞白血病患者的临床特征和结局：单机构报告。
Biomol Biomed. 2023 Mar 16;23(2):298-309. doi: 10.17305/bjbms.2022.7851.
8
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.《世界卫生组织造血与淋巴组织肿瘤分类》第五版：淋巴肿瘤。
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
9
Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia-The State-of-the-Art Knowledge and Future Prospects.克服小儿急性淋巴细胞白血病的类固醇耐药性——最新知识和未来展望。
Int J Mol Sci. 2022 Mar 30;23(7):3795. doi: 10.3390/ijms23073795.
10
What Is the Role of HSCT in Philadelphia-Chromosome-Positive and Philadelphia-Chromosome-Like ALL in the Tyrosine Kinase Inhibitor Era?在酪氨酸激酶抑制剂时代，异基因造血干细胞移植在费城染色体阳性和费城染色体样急性淋巴细胞白血病中起什么作用？
Front Pediatr. 2022 Feb 2;9:807002. doi: 10.3389/fped.2021.807002. eCollection 2021.
Zotero 插件